Ramadan Challenges: Fasting Against Medical Advice

Document Type: Review Article

Authors

1 Clinical Professor, UAE University, Endocrine Consultant, Tawam Endocrine Diabetes Center, SEHA, UAE

2 Endocrine Consultant, Tawam Endocrine Diabetes Center, SEHA, UAE

3 Honorary Professor, Institute of Public Health, UAE University

Abstract

Introduction: Fasting against medical advice (FAMA) is a major challenge for many physicians who treat patients with diabetes during the month of Ramadan. The significance of this phenomenon has not been evaluated in Muslim populations. The goal of this study was to assess the rate and consequences of FAMA in our high-risk patients. Methods: This is a retrospective case-control study. Patients were divided into two groups: (Group A) included high risk patients who decided to fast against the advice of their health care providers, and (Group B) included the low risk patients who were permitted to fast. Results: A total of 401 patients were evaluated. Out of the whole group, 147 patients were categorized as high risk for fasting. (Group A) included 111/147 patients who decided to fast against medical advice and (Group B) included 254 patients permitted to fast. The average number of fasted days and the proportion of patients who were able to fast the whole month were smaller in Group A than Group B (26±3 SD and 51% versus 29±1 SD and 87%, respectively, P<0.001). Severe hypoglycemia was significantly higher in Group A than group B (63% and 50% respectively, P=0.039). Conclusions: The majority of our high-risk patients elect to observe fasting in the month of Ramadan against the advice of their medical team. Patients who insisted on fasting against medical advice were more likely to break their fast due to hypoglycemia or other causes.

Keywords


  1.  Hassanein M, Al-Arouj M, Hamdy O, Bebakar WM, Jabbar A, Al-Madani A, et al. International Diabetes Federation (IDF), in collaboration with the Diabetes and Ramadan (DAR) international alliance. Diabetes and Ramadan: practical guidelines. Diabetes Res Clin Prat. 2017; 126:303-16.
  2. Al-Arouj M, Assaad-Khalil S, Buse J, Fahdil I, Fahmy M, Hafez S, et al. Recommendations for management of diabetes during Ramadan. Diabetes Care. 2010; 33(8):1895-902.
  3. Salti I, Bénard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries. Diabetes Care. 2004; 27(10):2306-11.
  4. Babineaux SM, Toaima D, Boye KS, Zagar A, Tahbaz A, Jabbar A, et al. Multi-country retrospective observational study of the management and outcomes of patients with type 2 diabetes during Ramadan in 2010 (CREED). Diabetic Med. 2015; 32(6):819-28.
  5. Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the American diabetes association and the endocrine society. J Clin Endocrinol Metab. 2013; 98(5):1845-59.
  6. Longest and shortest fasting times around the world. Fasting Hours Around the World. Available at: URL: https://ciiradio.com/2017/ 05/26/longest-and-shortest-fasting-times-around- the-world-ramadan; 2017.
  7. Tehran Weather. AccuWeather of Tehran Iran. Available at: URL: https://www.accuweather.com/ en/ae/alain/321660/juneweather/321660?monyr=6/1/2017; 2017.
  8. Kaplan W, Afandi B. Blood glucose fluctuation during Ramadan fasting in adolescents with type 1 diabetes: findings of continuous glucose monitoring. Diabetes Care. 2015; 38(10): e162-3.
  9. Alghadyan AA. Retinal vein occlusion in Saudi Arabia: possible role of dehydration. Ann Ophthalmol. 1993; 25(10):394-8.
  10. Bonakdaran SH, Khajeh-Dalouie M. The effects of fasting during Ramadan on glycemic excursions detected by continuous glucose monitoring system (CGMS) in patients with type 2 diabetes. Med J Malaysia. 2011; 66(5):447-50.
  11. Abdelgadir EI, Hafidh K, Basheir AM, Afandi BO, Alawadi F, Rashid F. Comparison of incidences, hospital stay and precipitating factors of diabetic ketoacidosis in Ramadan and the following month in three major hospitals in United Arab Emirates. A prospective observational study. J Diabetes Metab. 2015; 6(514):2.
  12. Bernieh B, Al Hakim MR, Boobes Y, Abu Zidan FM. Fasting Ramadan in chronic kidney disease patients: clinical and biochemical effects. Saudi J Kidney Dis Transpl. 2010; 21(5):898-902.
  13. Salim L, Al Suwaidi J, Ghadban W, Alkilani H, Salam AM. Impact of religious Ramadan fasting on cardiovascular disease: a systematic review of the literature. Curr Med Res Opin. 2013; 29(4):343-54.
  14. Abuelmagd W, Afandi B, Håkonsen H, Khmidi S, Nair SC, Toverud EL. Health information needs of women with Diabetes at a tertiary care hospital in United Arab Emirates. Poster session, 4th Gulf AACE Chapter meeting, Dubai; 2016.
  15. Afandi B, Kaplan W, Al Hassani N, Hadi S, Mohamed A. Correlation between pre-ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with Type 1 diabetes. J Endocrinol Invest. 2017; 40(7):741-4.
  16. Kaplan W, Afandi B, Al Hassani N, Hadi S, Zoubeidi T. Comparison of continuous glucose monitoring in adolescents with type 1 diabetes: Ramadan versus non-Ramadan. Diabetes Res Clin Pract. 2017; 134:178-82.
  17. Beshyah SA. Fasting during the month of Ramadan for people with diabetes: medicine and Fiqh united at last. Ibnosina J Med Biomed Sci. 2009; 1(2):58-60.
  18. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 2008(358):2545-59.
  19. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008; 2008(358):2560-72.
  20. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009; 360(2):
    129-39.